Quantinno Capital Management LP increased its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 78.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 331,731 shares of the health services provider's stock after buying an additional 145,588 shares during the quarter. Quantinno Capital Management LP owned approximately 0.19% of Teladoc Health worth $3,015,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. Whipplewood Advisors LLC bought a new position in shares of Teladoc Health during the 4th quarter worth approximately $29,000. Lindbrook Capital LLC raised its stake in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after acquiring an additional 1,612 shares during the period. Sterling Capital Management LLC raised its position in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after purchasing an additional 4,101 shares during the period. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $60,000. Finally, Generali Investments Management Co LLC acquired a new position in Teladoc Health during the 4th quarter valued at about $64,000. 76.82% of the stock is owned by institutional investors.
Insider Activity at Teladoc Health
In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. This trade represents a 14.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.58% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several research analysts recently commented on the company. Stifel Nicolaus reduced their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. The Goldman Sachs Group dropped their price target on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Citigroup cut their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a report on Friday, April 25th. Evercore ISI cut their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a research note on Thursday, May 1st. Finally, Bank of America lowered their target price on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $9.71.
View Our Latest Report on Teladoc Health
Teladoc Health Price Performance
Shares of Teladoc Health stock traded down $0.09 during trading hours on Friday, hitting $6.82. The company's stock had a trading volume of 4,118,390 shares, compared to its average volume of 6,248,706. The business has a 50 day moving average price of $7.42 and a two-hundred day moving average price of $9.29. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The company has a market cap of $1.20 billion, a PE ratio of -1.18 and a beta of 1.82. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.
Teladoc Health Profile
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
